Crisis-Ready: Building a Resilient Supply
How can European pharma better prepare for future emergencies?
Maryam Mahdi | | Quick Read
Drawing on lessons learned from the COVID-19 pandemic, the European Commission has developed a plan to secure affordable medicines for patients across the region (1). Pharmaceutical Strategy for Europe aims to create a regulatory approach that offers guidance on the management of future crises and supply chain resilience. The strategy also outlines the Commission’s goals for creating a competitive industry with a “strong voice” on issues affecting the global pharmaceutical community.
“Moving forward, there are too many public health, social and economic interests at stake here to get this wrong,” said Medicines for Europe President Christoph Stoller in a statement (2). “We strongly believe that all concerned stakeholders need to work together […] if we are to effectively deliver on the strategy’s ambition and ensure that patients receive the medicines they need when they need them, while keeping a strong, resilient and sustainable manufacturing base in Europe.”
For more information about the plan, visit https://bit.ly/36XJJoW.